Migraine

Migraine medicines are treatments designed to relieve the distinctive symptoms of migraine attacks — typically moderate to severe, often one-sided head pain accompanied by sensitivity to light or sound, nausea, or visual changes. Some products focus on aborting an attack once it begins, while others are intended to reduce the frequency and severity of future attacks when taken regularly. The category covers both short-term therapies for acute relief and longer-term preventive options for people who experience frequent or disabling migraines.

Many people use acute migraine medicines at the first sign of an attack to try to stop symptoms before they worsen. Acute options are chosen to match how quickly symptoms develop, how long they last, and whether nausea or vomiting is present. Preventive medicines are generally used on a regular schedule and are considered when attacks are frequent, predictably tied to triggers, or do not respond well to acute treatments. There are also transitional or rescue approaches for prolonged or treatment-resistant episodes that require more intensive management under clinical supervision.

The category contains several classes of drugs. Triptans are a common prescription class for acute migraine and include agents such as sumatriptan (often known by the brand Imitrex), rizatriptan (Maxalt), and zolmitriptan (Zomig); these are available in different formulations like tablets, orally disintegrating wafers, nasal sprays, and injectables. Over-the-counter pain relievers and anti-inflammatory medicines (for example, products containing ibuprofen or naproxen) are often used for milder attacks or in combination with other treatments. Antiemetic medicines that help control nausea and increase absorption of oral drugs are also part of the toolkit. Newer options target the calcitonin gene-related peptide (CGRP) pathway and include both preventive injectable antibodies and oral small-molecule antagonists (sometimes called gepants) for acute relief. Preventive strategies may use medications from other therapeutic areas, such as certain beta-blockers, some antiepileptic drugs, and some antidepressants, as well as injectable neurotoxin therapy for chronic migraine under specialist care.

Safety considerations are an important aspect when selecting migraine medicines. Different medicine classes have different side effect profiles and interaction potentials, and some formulations are prescription-only. Certain acute therapies may affect the cardiovascular system or interact with other drugs that influence serotonin levels, while preventive agents can have effects related to blood pressure, weight, mood, or cognitive function depending on the class. Pregnancy, breastfeeding, chronic medical conditions, and current medications can influence which options are appropriate. Product labeling, a prescribing clinician’s guidance, and the pharmacy-provided information explain potential risks and common adverse effects without replacing individualized medical assessment.

When comparing products, users typically consider how quickly a medicine begins to work and how long relief lasts, whether a product must be taken repeatedly during an attack, and which delivery methods are most practical given symptoms such as nausea. Other deciding factors include tolerability of side effects, the convenience of dosing schedules, whether a product is prescription-only or available over the counter, and whether generic alternatives are available. For many people, balancing fast onset against duration of effect and potential adverse effects is central to selecting an option that fits their lifestyle and symptom pattern.

Product descriptions on this site generally indicate the active ingredient, available formulations, and relevant safety information, along with links to official patient information leaflets. Users often review factors such as formulation (tablet, wafer, nasal spray, injectable), storage guidance, and whether a product is commonly used for episodic versus chronic migraine. Pharmacies can facilitate prescription fulfillment, refills, and transfers, but decisions about starting, stopping, or changing therapies are best made in consultation with a healthcare professional who can interpret individual health history and concurrent medications.